SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)

Q: What does CUSIP 85205L107 represent in this 13F holders report?

CUSIP 85205L107 is the security identifier for SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in Q4 2020?

123 institutional investors reported SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share for Q4 2020. Use the holders table for investor-level position and value details.

CUSIP: 85205L107

Q4 2020 13F Holders as of 31 Dec 2020

Security type / class: Equity / Common Stock, par value $.0001 per share
Total 13F shares: 43,386,194
Total 13F value: $3,146,822,308
Share change: +5,903,887
SEC-reported price per share: $72.52
Number of holders: 123
Value change: +$421,342,946
Number of buys: 93
Number of sells: 22
Shares outstanding: 75,607,738

Security key

85205L107

Report period

Q4 2020

Institutions

123

Top holders

SWTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 SpringWorks Therapeutics, Inc. SEC filings SpringWorks Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 85205L107

Newer quarter: Q4 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025

Ownership snapshot

Top reported holders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

30 Sep 2020

13F Highest disclosed value: $353,059,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $353.06M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $353.06M

Bain Capital Life Sciences Invest... $347.1M

PERCEPTIVE ADVISORS LLC $165.95M

Boxer Capital, LLC $98.96M

BVF INC/IL $97.91M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$353,059,000 7,406,307 shares	—	30 Sep 2020
Bain Capital Life Sciences Investors, LLC	13F Company 13F	— denominator unverified	$347,100,000 7,281,307 shares	—	30 Sep 2020
PERCEPTIVE ADVISORS LLC	13F Company 13F	— denominator unverified	$165,946,000 3,481,148 shares	—	30 Sep 2020
Boxer Capital, LLC	13F Company 13F	— denominator unverified	$98,958,000 2,075,905 shares	—	30 Sep 2020
BVF INC/IL	13F Company 13F	— denominator unverified	$97,914,000 2,053,991 shares	—	30 Sep 2020
FMR LLC	13F Company 13F	— denominator unverified	$74,819,000 1,569,512 shares	—	30 Sep 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

123

43,386,194

Rows available

123

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q1 2026 Across Filers

Q1 2026 holders

Q4 2020 holders

123

Holder diff

122

Investor	Q1 2026 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q1 2026 value	Q4 2020 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend